chr4-121801853-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005033.3(EXOSC9):āc.93T>Gā(p.Asp31Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005033.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXOSC9 | NM_005033.3 | c.93T>G | p.Asp31Glu | missense_variant | 2/12 | ENST00000243498.10 | NP_005024.2 | |
EXOSC9 | NM_001034194.2 | c.93T>G | p.Asp31Glu | missense_variant | 2/13 | NP_001029366.1 | ||
EXOSC9 | XM_011532035.4 | c.93T>G | p.Asp31Glu | missense_variant | 2/11 | XP_011530337.1 | ||
EXOSC9 | XR_007057929.1 | n.195T>G | non_coding_transcript_exon_variant | 2/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXOSC9 | ENST00000243498.10 | c.93T>G | p.Asp31Glu | missense_variant | 2/12 | 1 | NM_005033.3 | ENSP00000243498.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461550Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727110
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.93T>G (p.D31E) alteration is located in exon 2 (coding exon 2) of the EXOSC9 gene. This alteration results from a T to G substitution at nucleotide position 93, causing the aspartic acid (D) at amino acid position 31 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.